A high-drug-loading self-assembled nanoemulsion enhances the oral absorption of probucol in rats

Journal of Pharmaceutical Sciences

Volumn 102, Issue 4, 2013, Pages 1301-1306

  Zhang, Zhiwen ^a   Huang, Jian ^b   Jiang, Shijun ^c   Liu, Zeying ^c   Gu, Wangwen ^a   Yu, Haijun ^a   Li, Yaping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b JIANGSU UNIVERSITY   (China)

^c EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bioavailability; Calorimetry (DSC); Intestinal absorption; Nanoemulsion; Oral drug delivery; Pharmacokinetics; Poorly water soluble drug; Probucol; Self assembly

Indexed keywords

PROBUCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DUODENUM; ILEUM; INTESTINE ABSORPTION; JEJUNUM; NANOEMULSION; NONHUMAN; RAT;

EID: 84874723456     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23460     Document Type: Article

References (25)

1. Porter CJH, Trevaskis NL, Charman WN. 2007. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6:231-248.
2. Zhang Z, Bu H, Gao Z, Huang Y, Gao F, Li Y. 2010. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm 394:147-153.
3. Kohli K, Chopra S, Dhar D, Arora S, Khar RK. 2010. Self-emulsifying drug delivery system: An approach to enhance oral bioavailability. Drug Discov Today 15:958-965.
4. Savjani KT, Gajjar AK, Savjani JK. 2012. Drug solubility: Importance and enhancement techniques. ISRN Pharm 2012:195727
5. Pater VR, Agrawal YK. 2011. Nanosuspension: An approach to enhance solubility of drugs. J Adv Pharm Technol Res 2:81-87.
6. Brewster ME, Loftsson T. 2007. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59:645-666.
7. Vasconcelos T, Sarmento B, Costa P. 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 12:1068-1075.
8. Zhang Z, Huang Y, Gao F, Gao Z, Bu H, Gu W, Li Y. 2011. A self-assembled nanodelivery system enhances the oral bioavailability of daidzein: In vitro characteristics and in vivo performance. Nanomedicine (Lond) 6:1365-1379.
9. Bromberg L. 2008. Polymeric micelles in oral chemotherapy. J Control Release 128:99-112.
10. Zhang Z, Gao F, Bu H, Xiao J, Li Y. 2012. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: In vitro characteristics and absorption mechanism in rats. Nanomedicine 8:740-747.
11. Wang X, Fan J, Liu Y, Zhao B, Jia Z, Zhang Q. 2011. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm 419:339-346.
12. Marasini N, Yan YD, Poudel KB, Choi HG, Yong CS, Kim JO. 2012. Development and optimization of self-nanoemulsifying drug delivery system with enhanced bioavailability by Box-Behnken design and desirability function. J Pharm Sci 101:4584-4596.
13. Rabinow BE. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785-796.
14. Date AA, Dixit R, Nagarsenker M. 2010. Self-nanoemulsifying drug delivery systems: Formulation insights, applications and advances. Nanomedicine (Lond) 5:1595-1616.
15. Elnaggar YS, El-Massik MA, Abdallah OY. 2009. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm 380:133-141.
16. Gao F, Zhang Z, Bu H, Huang Y, Gao Z, Shen J, Zhao C, Li Y. 2011. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism. J Control Release 149:168-174.
17. Mudie DM, Amidon GL, Amidon GE. 2010. Physiological parameters for oral delivery and in vitro testing. Mol Pharm 7:1388-1405.
18. Roger E, Lagarce F, Garcion E, Benoit JP. 2010. Biopharmaceutical parameters to consider in order to alter the fate of naocarriers after oral delivery. Nanomedicine (Lond) 5:287-306.
19. Hearnden V, Sankar V, Hull K, Juras DV, Greenberg M, Kerr AR, Lockhart PB, Patton LL, Porter S, Thornhill MH. 2012. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 64:16-28.
20. Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. 2009. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 133:238-244.
21. Peltier S, Oger JM, Lagarce F, Couet W, Benoit JP. 2006. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res 23:1243-1250.
22. Buyukozturk F, Benneyan JC, Carrier RL. 2010. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release 142:22-30.
23. Zhang Z, Gao F, Jiang S, Ma L, Li Y. 2012. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism. Curr Drug Metab 13:1110-1118.
24. Yap SP, Yuen KH. 2004. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int J Pharm 281:67-78.
25. Roger E, Lagarce F, Garcion E, Benoit JP. 2009. Lipid nanocarriers improve paclitaxel transport through human intestinal epithelial cells by using vesicle-mediated transcytosis. J Control Release 140:174-181.